Over twenty years in business with a combined staff experience totaling more than 100 years, we are the global leader in the fields of vector biology & wildlife research. Genesis Labs has completed over 2,500 projects in over 60 countries and proven that we provide quality services to our clients. Our team of highly qualified professionals strives for excellence with every project.
Genesis Laboratories, Inc. is a full service laboratory located in the foothills of the Rocky Mountains in Colorado. We provide a vast array of services to clients involved in the agrochemical and pharmaceutical industries, rodenticide research and development, as well as invasive species, zoonotic disease, and conservation research.
Established in 1989, Genesis has earned a reputation for quality work conducted in a timely manner. Our staff of scientists assists with the development of novel products and the improvement of existing products. We are also involved in a wide variety of risk assessment techniques and implementation of management strategies concerning the control of invasive and native species. If required, our research can be completed under Good Laboratory Practice (GLP) standards, primarily for FIFRA (EPA), OECD or FDA registrations. Our Quality Assurance program ensures the best in experimental design, data accuracy, and quality service. Genesis prides itself responding to new, challenging research needs of the industry. If an uncommon service you need is not found on this website, please contact us to discuss how we might be able to assist you in research design and evaluation. Our innovative ideas and techniques have led to Genesis receiving numerous Small Business Innovative Research Grants in the last five years.
As a leader in wildlife research, we strive to provide quality research. The staff at Genesis Laboratories, Inc. has amassed over 80 years of extensive experience in the laboratory and field in the United States and 50 countries around the world. One of our primary objectives is to ensure the protection of our native wildlife.
Genesis Laboratories has also established the Richland Foundation/Invasive Species Management (ISM), a 501(c)3 non-profit, established to combat the effects of invasive species. Our experience in vertebrate pest management and our strong work ethic have been combined for the conservation of sensitive ecosystems and animals. Additionally, we use our expertise to assist developing countries in environmental management, disease control, and agriculture development.
Over the past 22 years our staff has caputed some amazing images from all over the world, so we have created this gallery to showcase some of the places and people we have encountered. Even though our business is bugs and wildlife, our main goal is helping others. We find that in each country the kiddos are facinated by the camera and always in front of it. Our owner Richard Poche has learned to shoot from the hip without their knowledge- some of our favorite candid shots! We hope that you enjoy the picutes as much as we do.
U.S. Department of Defense, Deployed Warfighters Protection Program (2010-2011)
Combined systemic and feed-through control of adult and larval sand flies: studies using fat sand rats (Psammomys obesus) and jirds (Meriones spp).
U.S. Department of Defense, Deployed Warfighters Protection Program (2008)
Combined systemic and feed-through control of adult and larval sand flies using host-targeted insecticide: laboratory and field studies
Turn the Corner Foundation (2007)
Decreasing the risk of Lyme disease by using an extruded
rodent bait containing doxycycline.
The Bill and Melinda Gates Foundation Project in India (2009-2011)
Leishmaniasis, also called black fever or kala-azar is the second most prevalent vector-borne disease in the world, surpassed only by malaria. Vector-borne diseases carried by animals - most often an insect that feeds on blood and delivers a parasite or virus during its blood meal. There are three types leishmaniasis caused by a number of parasite species within the genus Leishmania. The most dangerous type is visceral leishmaniasis which attacks the organs and without an extended period of treatment is almost always fatal. Although leishmaniasis is found in 62 countries including the United States. India has more cases and higher mortalities due to visceral leishmaniasis than any country in the world.
Genesis Laboratories has received a Bill and Melinda Gates Foundation grant to conduct research on potential reservoir
hosts of leishmaniasis with the objective of developing methods to prevent the disease rather than cure it. Our work in India is located in the Bihar Province, the state where most of the cases occur, and we have come up with some exciting, new ideas.
US Fish & Wildlife Service (2008)
Develop standard protocols for conducting, monitoring, and evaluating the reintroduction of Key Largo Woodrats.
Louisiana Department of Natural Resources
Conduct a comprehensive review of published and unpublished data related to all appropriate population control methods and analyze their applicability to controlling nutria in Louisiana: A Nutria management plan.
National Fish & Wildlife Foundation (2007)
Small mammal inventory of Horn Island
U.S. Department of Agriculture, Small Business Innovation Research Grant (2004)
A novel rodent bait to reduce Lyme disease risks
U.S. Department of Agriculture, Small Business Innovation Research Grant (2005)
A novel bait to control Nutria, Phase I.
U.S. Department of Agriculture, Small Business Innovation Research Grant (2006)
A novel bait to control Nutria, Phase II.
U.S. Department of Agriculture, Small Business Innovation Research Grant (2008)
Development of a novel hog toxicant, Phase I.
National Insitute of Health, Center for Disease Control & Small Business Innovation Research Grant (2003)
Flea control on rodents using systemic insecticides, Phase I.
National Insitute of Health, Center for Disease Control & Small Business Innovation Research Grant (2004)
Flea control on rodents using systemic insecticides, Phase II.
29 West 21st Street, Suite 750
New York, New York 10010 USA
main +1.212.403.1398
fax +1.686.369.5985